Loading
Efinia is an experimental wearable device from EMBioSys, a tank top that sends a weak electric field into breast tumours at home. It is not FDA cleared.
Efinia is the investigational induced electric field (iEF) therapy garment of EMBioSys, designed for breast cancer treatment at home while patients wait for surgery. An NCI SBIR award to EMBioSys funds the CuRrEnT study of Efinia's electric field with capecitabine in triple-negative breast cancer with residual disease. No efficacy results have been published.
A tank-top garment with a battery-powered module delivers a low-intensity induced electric field to the breast, without electrodes or heating, as the developer describes.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Efinia" OR ABSTRACT:"Efinia") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Efinia, not a curated reading list.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/